Navigation Links
S1 Biopharma Supports FDA Advisory Committee's Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder
Date:6/5/2015

NEW YORK, June 5, 2015 /PRNewswire/ -- Yesterday's FDA Advisory Committee recommendation for the approval of flibanserin was a landmark step for women's health, addressing the important unmet medical need for women living with hypoactive sexual desire disorder, or HSDD.  We are especially pleased for S1 Biopharma's Dr. Robert Pyke who fathered flibanserin at Boehringer Ingelheim before it was acquired by Sprout Pharmaceuticals.  Dr. Pyke joined S1 Biopharma as Chief Medical Officer in 2012 to develop our next-generation drug for HSDD, Lorexys.

HSDD is a medical condition marked by a lack of sexual thoughts and desire for sexual activity that cannot be accounted for by another medical, physical, or psychiatric condition, or medication.  An estimated 1 in 10 women may have HSDD at some point in their life, for which therapies like flibanserin with a 9%- 13% responder rate over placebo, and S1 Biopharma's first in class, next-generation drug Lorexys have been developed to address.

S1 Biopharma is currently preparing for upcoming Phase IIb studies for Lorexys for the treatment of HSDD.  In its recently completed Phase IIa study, Lorexys demonstrated a 76% responder rate that was 38% greater than control.

About S1 Biopharma

S1 Biopharma is a developer of first-in-class drugs for sexual dysfunction in both women and men. The company's pipeline of therapies is non-hormonal, acting on the sexual centers of the brain by restoring the natural balance of key neurotransmitters. S1 Biopharma's pipeline utilizes its trademark philosophy of identifying and combining mechanistically opposing agents that work synergistically to maximize beneficial effects on sexual function while minimizing side effects. The company's lead compound, Lorexys, recently completed a Phase IIa clinical trial for the treatment of hypoactive sexual desire disorder (HSDD).

For more information please visit www.s1biopharma.com.

Contact:
Nick Sitchon
nsitchon@s1biopharma.com
212-895-8915


'/>"/>
SOURCE S1 Biopharma
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma
2. EMD Millipore Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production
3. Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting
4. PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference
5. Array BioPharma To Present At The Jefferies 2015 Global Healthcare Conference
6. Technical Coverage on Biotech Stocks -- Anthera Pharma, RXi Pharma, MiMedx, Sarepta Therapeutics, and Navidea Biopharma
7. Intarcia Named To "CNBC Disruptor 50" List: One Of Only Two Biopharma Companies Named
8. DS Biopharma to Present at UBS Global Healthcare Conference
9. WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition
10. CTI BioPharma Reports First Quarter 2015 Financial Results
11. PDL BioPharma Announces First Quarter 2015 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2019)... LAKES, Fla. (PRWEB) , ... January 14, 2019 ... ... and distributing Cushion Grip, Thermoplastic Denture Adhesive, to the U.S. market. Bayer ... Bayer’s multinational product rights concerning the CUSHION GRIP brand to USpharma. Since ...
(Date:1/14/2019)... ... January 13, 2019 , ... Datalogic , a global leader ... Memor™ 10 rugged mobile computer , one of the few rugged devices validated ... of a new family of rugged Android PDA devices from Datalogic. It offers ...
(Date:1/11/2019)... ... 2019 , ... Isagenix International , known for its ... health. The global health and wellness company just launched IsaBiome™ Daily Digestive Health ... better daily digestion of meals and long-term gut health.† The products were designed ...
Breaking Medicine Technology:
(Date:1/21/2019)... ... ... imaware(TM) , an at-home testing platform for chronic illness and diseases designed by ... with Celiac Disease. The platform now includes an easy-to-use monitoring test for those who ... changes. The new monitoring test follows the company’s recent launch of its ...
(Date:1/20/2019)... , ... January 18, 2019 , ... Park Cities Pet Sitter has just announced a promotion to kick off the ... service with the company will receive three free weeks of walks during that time. ... a set schedule. A client would need to utilize a minimum of three walks per ...
(Date:1/20/2019)... PETALUMA, Calif. (PRWEB) , ... January 18, 2019 ... ... senior care experts, recently made its debut in Entrepreneur magazine’s Franchise 500, the ... is a highly sought-after honor in the franchise industry, as evidenced by the ...
(Date:1/20/2019)... ... January 19, 2019 , ... With more than 20 years ... quality and delivery of health care services to SCFHP members via medical oversight ... Services and Supports and Behavioral Health. In addition, she oversees the development and ...
(Date:1/15/2019)... MOUNTAIN VIEW, Calif. (PRWEB) , ... January 15, 2019 , ... ... is pleased to announce the opening of yet another office location for the thriving ... 94040. The new clinic is slated to open in mid-February and will offer the ...
Breaking Medicine News(10 mins):